| |
|
Form Serial Number: |
CS20260618E00196 |
| 1.
Date of relevant event: |
18/06/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
06990 |
| 4.
Name of listed corporation: |
四川科倫博泰生物醫藥股份有限公司 - H股 |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
170,984,257 |
| 7.
Name of substantial shareholder: |
成都科伦晶川科技有限公司 |
| 8.
Registered office: |
中国成都市温江区成都海峡两岸科技产业开发园新华大道666号 |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
Sichuan Kelun Pharmaceutical Co., Ltd. (Shenzhen Stock Exchange) |
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1213 | The percentage level of your interest in the shares has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
75,400 |
HKD |
423.4000 |
412.7400 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 25,656,100 | 15.00 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 25,580,700 | 14.96 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 成都科伦汇德企业管理中心(有限合伙) | 中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国） | 成都科伦晶川科技有限公司(作为普通合伙人) | 100.00 | Y | |
| 成都科伦汇能企业管理中心(有限合伙) | 中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国） | 成都科伦晶川科技有限公司(作为普通合伙人) | 100.00 | Y | |
| 成都科伦汇智企业管理中心(有限合伙) | 中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国） | 成都科伦晶川科技有限公司(作为普通合伙人) | 100.00 | Y | |
| 成都科伦汇才企业管理中心(有限合伙) | 中国成都市温江区成都海峡两岸科技产业开发园新华大道666号（中国） | 成都科伦晶川科技有限公司(作为普通合伙人) | 100.00 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
有关方格17而言，科伦晶川为科伦博泰员工持股平台科伦汇德、科伦汇能、科伦汇智、科伦汇才的普通合伙人，由于四个员工持股平台于2026年6月18日于二级市场出售科伦博泰股票，合计出售数量不超过科伦博泰当日成交量的10%，进而科伦晶川所控制的科伦博泰股份数量减少且比例下降。
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
18/06/2026
(dd/mm/yyyy)
|
|
|
|
|